CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19-Reference-Cited by-同舟云学术

CXCL16 associates with adverse outcome and cardiac involvement in hospitalized patients with Covid-19

Published:2022-12 Issue:6 Volume:85 Page:702-769
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Gregersen Ida,Ueland Thor,Holter Jan Cato^ORCID,Olsen Maria Belland,Michelsen Annika E^ORCID,Murphy Sarah L,Tveita Anders Aune^ORCID,Henriksen Katerina Nezvalova,Hoel Hedda,Nordberg Lena Bugge,Holten Aleksander Rygh,Edvardsen Thor,Yang Kuan^ORCID,Heggelund Lars,Trøseid Marius^ORCID,Müller Fredrik,Kildal Anders Benjamin^ORCID,Dyrhol-Riise Anne Ma,Barratt-Due Andreas,Dahl Tuva B^ORCID,Aukrust Pål^ORCID,Halvorsen Bente

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference9 articles.

1. Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with Covid-19-associated pneumonia;Kim;J Infect,2022

2. Genomewide association study of severe Covid-19 with respiratory failure;Ellinghaus;N Engl J Med,2020

3. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes;Jansson;Circulation,2009

4. Fatty acid-binding protein 3 and CXC-chemokine ligand 16 are associated with unfavorable outcome in aneurysmal subarachnoid hemorrhage;Schranz;J Stroke Cerebrovasc Dis,2021

5. Clinical and biological markers for predicting ARDS and outcome in septic patients;Villar;Sci Rep,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-22 is increased in hospitalized patients with COVID-19 and associates with cardiac involvement;Journal of Infection;2024-07

2. sCXCL16 as a prognostic biomarker for COVID‐19 outcome;Journal of Medical Virology;2023-04